EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy, Safety and Biological Characteristics of Formulation Based on Essential Oil Against Co‐Infections of Herpes Simplex Virus‐1 and Candida albicans

Maura Di Vito, Domiziana Coggiatti, Marilena La Sorda, Stefania Garzoli iD, Giulia Lombardini, Debora Talamonti, Scilla Pizzarelli, Abdesselam Zhiri, Margherita Cacaci, Riccardo Torelli, Maurizio Sanguinetti iD, Francesca Bugli

MicrobiologyOpen · 2026-02 · 15 (1)

DOI: 10.1002/mbo3.70199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MicrobiologyOpen, online erschienen am 14.01.2026. Verfasst von Maura Di Vito und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy. Hauptthemen laut MEDLINE: Oils, Volatile, Candida albicans, Herpesvirus 1, Human, Coinfection. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU funding within the MUR PNRR Extended Partnership Initiative on Emerging Infectious Diseases, Linea di finanziamento di ateneo D1, Università Cattolica del Sacro Cuore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral coinfections involving herpes simplex virus (HSV) and Candida albicans can potentially interact and exacerbate each other. Starting from bibliographical investigation, this study aimed to examine the effectiveness of some essential oils (EOs), and their commercial formulations, both against C. albicans and HSV‐1, identifying their antimicrobial, anti‐inflammatory and allergenic potential. A preliminary review examined essential oils' efficacy against HSV‐1. Broth microdilution tested 14 EOs, a commercial formulation (LA), and a homemade one (MIX) against three fungal strains. The quality of LA, MIX and single EOs was assessed by Solid Phase Microextraction (SPME) sampling coupled with gas chromatography‐mass spectrometry (GC‐MS) analysis. To assess the allergenic activity of MIX, LA, and single EOs a Basophil Activation Test (BAT) was standardized. ELISA tests were done to evaluate the anti‐inflammatory activity. The bibliographic search highlighted seven EOs active against HSV‐1. Four EOs showing strong antifungal activity were blended, following IFRA lip‐application limits, to create a formulation (MIX) for comparison with a commercial herpes treatment (LA). Formulations were active against HSV‐1, able to modulate the expression of pro (TNF‐α LA = −29.7% and TNF‐α MIX = −33.6%) and anti‐inflammatory (IL‐1β LA = −50.0% and IL‐1β MIX = −25.0%) cytokines and no allergenic. MIX reinforces target cells and blocks viral entry, while LA also limits intracellular replication. EO‐based formulations show promise for managing HSV‐1 and Candida co‐infections, offering antiviral, antifungal, and anti‐inflammatory effects. BAT results indicate no basophil activation at tested concentrations, supporting their safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oils, VolatileCandida albicansHerpesvirus 1, HumanCoinfectionAntifungal AgentsAntiviral AgentsCandidiasisHerpes SimplexHumansAnti-Inflammatory AgentsAnimalsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

antifungal activityantiviral activityanti‐inflammatory activitybasophil activation testco‐infection

Substanzen

Oils, VolatileAntifungal AgentsAntiviral AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
  • Dipartimento di Chimica e Tecnologie del Farmaco, Università di Roma Sapienza, Rome, Italy.
  • Knowledge Unit (Documentation, Library), Istituto Superiore di Sanità, Rome, Italy.
  • R&D Department, Pranarom international 37, Avenue des Artisans, Ghislemghien, Belgium.
  • Plant Biotechnology Research Unit, Université Libre de Bruxelles (ULB), Brussels, Belgium.

ORCID-Profile: Stefania Garzoli, Maurizio Sanguinetti

Förderung

  • EU funding within the MUR PNRR Extended Partnership Initiative on Emerging Infectious Diseases
  • Linea di finanziamento di ateneo D1, Università Cattolica del Sacro Cuore

Zitieren

APA

Di Vito, M., Coggiatti, D., La Sorda, M., Garzoli, S., Lombardini, G., Talamonti, D., Pizzarelli, S., Zhiri, A., Cacaci, M., Torelli, R., Sanguinetti, M., & Bugli, F. (2026). Efficacy, Safety and Biological Characteristics of Formulation Based on Essential Oil Against Co‐Infections of Herpes Simplex Virus‐1 and Candida albicans. MicrobiologyOpen, 15(1). https://doi.org/10.1002/mbo3.70199

Vancouver

Di Vito M, Coggiatti D, La Sorda M, Garzoli S, Lombardini G, Talamonti D, et al. Efficacy, Safety and Biological Characteristics of Formulation Based on Essential Oil Against Co‐Infections of Herpes Simplex Virus‐1 and Candida albicans. MicrobiologyOpen. 2026;15(1). doi:10.1002/mbo3.70199

BibTeX
@article{DiVito2026,
  author = {Di Vito, Maura and Coggiatti, Domiziana and La Sorda, Marilena and Garzoli, Stefania and Lombardini, Giulia and Talamonti, Debora and Pizzarelli, Scilla and Zhiri, Abdesselam and Cacaci, Margherita and Torelli, Riccardo and Sanguinetti, Maurizio and Bugli, Francesca},
  title = {Efficacy, Safety and Biological Characteristics of Formulation Based on Essential Oil Against Co‐Infections of Herpes Simplex Virus‐1 and Candida albicans},
  journal = {MicrobiologyOpen},
  year = {2026},
  volume = {15},
  number = {1},
  doi = {10.1002/mbo3.70199}
}
Kostenlos starten →